Jason Brown
Cbo @Imu Biosciences
Signup · Get unlimited contacts
WORK HISTORY
Cbo @Imu Biosciences
London, GB
Building strategic partnerships with pharma and biotech companies to advance disease diagnosis, optimise product selection and improve patient stratification and monitoring.IMU Biosciences has developed proprietary platform technologies that generate and translate vast system-level immune data to deliver precision medicines across a variety of diseases. IMU leverages advanced immune profiling with proprietary AI and machine learning analytics to uncover novel clinical signatures.
EDUCATION
University of Cambridge
PhD, Molecular Biochemistry; Identified the molecular target of the Pfizer drugs Neurontin and Lyrica
University of Cambridge
MPhil, Molecular Biochemistry; Purified the molecular target of the Pfizer drugs Neurontin and Lyrica
University of Leicester
BSc (Hons) 2:i, Molecular Biochemistry and Genetics
ABOUT JASON BROWN
A biochemist and biotech entrepreneur with experience in pharma, biotech and start-ups across operational, scientific and commercial/partnering/BD roles.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.